(S)-(+)-α-Methylhistamine dihydrobromide

Pricing Availability Delivery Time Qty
Cat.No. 0572 - (S)-(+)-alpha-Methylhistamine dihydrobromide | C6H11N3.2HBr | CAS No. 75614-93-6
Description: H3 agonist, less active enantiomer
Chemical Name: (S)-(+)-α-Methyl-1H-imidazole-4-ethanamine dihydrobromide
Datasheet
Citations
Literature

Biological Activity

Less active enantiomer of H3 agonist R-(-)-α-methylhistamine (Cat. No. 0569); 120-fold less potent than R-(-) at H3.

Technical Data

M. Wt 287
Formula C6H11N3.2HBr
Storage Desiccate at RT
CAS Number 75614-93-6
PubChem ID 45073439
InChI Key RWHNAAABSGVRDT-XRIGFGBMSA-N
Smiles N[C@@H](C)CC1=CNC=N1.Br.Br

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

All Tocris products are intended for laboratory research use only.

Solubility Data

SolubilitySoluble to 100 mM in water

Preparing Stock Solutions

The following data is based on the product molecular weight 287. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.

Select a batch to recalculate based on the batch molecular weight:
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 3.48 mL 17.42 mL 34.84 mL
5 mM 0.7 mL 3.48 mL 6.97 mL
10 mM 0.35 mL 1.74 mL 3.48 mL
50 mM 0.07 mL 0.35 mL 0.7 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

Product Datasheets

Certificate of Analysis / Product Datasheet
Select another batch:
Safety Datasheet

References

References are publications that support the products' biological activity.

Hill (1990) Distribution, properties and functional characteristics of three classes of histamine receptor. Pharmacol.Rev. 42 45 PMID: 2164693


If you know of a relevant reference for (S)-(+)-α-Methylhistamine dihydrobromide, please let us know.

View Related Products by Target

View Related Products by Product Action

View all Histamine H3 Receptor Agonists

Keywords: (S)-(+)-alpha-Methylhistamine dihydrobromide, supplier, H3, agonists, Receptors, Histamine, histaminergic, (S)-(+)-alpha-Methylhistamine, dihydrobromide, Histamine, H3, Receptors, Tocris Bioscience

Citations for (S)-(+)-α-Methylhistamine dihydrobromide

Citations are publications that use Tocris products.

Currently there are no citations for (S)-(+)-α-Methylhistamine dihydrobromide. Do you know of a great paper that uses (S)-(+)-α-Methylhistamine dihydrobromide from Tocris? If so please let us know.

Commented out for usability testing

Reviews

TODO: Add Reviews

Literature in this Area

GPCR

GPCR Product Listing

A collection of over 450 products for G protein-coupled receptors, the listing includes research tools for the study of:

  • Rhodopsin-like Receptors
  • Secretin-like Receptors
  • Glutamate Receptors
  • Frizzled Receptors
  • GPCR Signaling
Histamine Receptors

Histamine Receptors Scientific Review

Written by Iwan de Esch and Rob Leurs, this review provides a synopsis of the different histamine receptor subtypes and the ligands that act upon them; compounds available from Tocris are listed.

Alzheimer's

Alzheimer's Poster

Alzheimer's disease (AD) is a degenerative brain disease and the most common cause of dementia, affecting approximately 47 million people worldwide. Updated in 2015, this poster summarizes the structural and functional changes observed in the progression of this neurodegenerative disease, as well as classic AD drug targets.

Asthma

Asthma Poster

Asthma is one of the most common chronic diseases in the world, affecting over 300 million people. This poster highlights key pathways and new therapies used to treat the condition, including those currently in clinical development.

Pathways for (S)-(+)-α-Methylhistamine dihydrobromide

Protocols

TODO: Add Protocols